<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03507816</url>
  </required_header>
  <id_info>
    <org_study_id>7002</org_study_id>
    <nct_id>NCT03507816</nct_id>
  </id_info>
  <brief_title>A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in Alsace</brief_title>
  <official_title>Epidemiology and Treatment of Multidrug-resistant (MDR TB) and Extensively Drug- Resistant (XDR TB) Tuberculosis in Strasbourg, France; a 10 Years Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the epidemiology of TB MR in Strasbourg and evaluate
      the second-line anti-tuberculosis treatments effectiveness, and the relevance and adequacy of
      the treatments with WHO recommendations. During years 2006-2016, all new cases of MDR TB or
      XDR TB diagnosed Strasbourg University Hospital will be included in the study (22 cases).
      Data were collected from the Center for Tuberculosis Control (CLAT) records, the patient's
      medical records.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 23, 2018</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Study of clinical characteristics of patients hospitalized at Strasbourg University Hospital from 2006 to 2016, with proven MDR or XDR tuberculosis</measure>
    <time_frame>The period from January 1st, 2006 to December 31st, 2016 will be examined</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Tuberculosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with proven MDR or XDR tuberculosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major patient (â‰¥18 years old)

          -  Patient hospitalized at Strasbourg University Hospital from 2006 to 2016, with proven
             MDR or XDR tuberculosis

        Exclusion Criteria:

        - Refusal of the patient to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Xavier ARGEMI, MD</last_name>
    <phone>33 3 69 55 11 87</phone>
    <email>xavier.argemi@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Magalie Paz, MD</last_name>
    <phone>33 3 69 55 11 87</phone>
    <email>magalie.paz@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Maladies Infectieuses et Tropicales</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier ARGEMI, MD</last_name>
      <phone>33 3 69 55 11 87</phone>
      <email>xavier.argemi@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Magalie PAZ, MD</last_name>
      <phone>33 3 69 55 11 87</phone>
      <email>magalie.paz@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Xavier ARGEMI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Magalie PAZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2018</study_first_submitted>
  <study_first_submitted_qc>April 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2018</study_first_posted>
  <last_update_submitted>April 26, 2018</last_update_submitted>
  <last_update_submitted_qc>April 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tuberculosis</keyword>
  <keyword>Multi-drug Resistant Tuberculosis</keyword>
  <keyword>Observational retrospective study</keyword>
  <keyword>Clinical epidemiology</keyword>
  <keyword>Treatment outcome</keyword>
  <keyword>Migrant</keyword>
  <keyword>Precarity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

